While it seems Kenilworth is still evaluating other development site options, this investment would tally a little over $20 million by the company, in building out the new facility. And even at double that, it would be a rounding error, to the finances of this Goliath global pharmaceutical and bio-science company.
We will keep you informed, as the hearings down by UT Austin Med School progress, on and after April 13, 2017.
Do travel well -- and do travel light, one and all. I'm out, for the night. . . . so keep it spinning in good karma! Smile.
नमस्ते
2 comments:
If it is just a rounding error to Merck finances then why seek economic incentives from local tax payers?
Great question, Anon. --
I think -- because they *can*. . .
That's the first rule of capitalism: get government to help pay your start-up costs. . .
Namaste. . . Do stop back!
Post a Comment